PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Kunzke, T. ; Hölzl, F.T. ; Prade, V.M. ; Buck, A. ; Huber, K. ; Feuchtinger, A. ; Ebert, K.* ; Zwingenberger, G.* ; Geffers, R.* ; Hauck, S.M. ; Haffner, I.* ; Luber, B.* ; Lordick, F.* ; Walch, A.K.

Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2-positive advanced gastric cancer.

Clin. Transl. Med. 11:e547 (2021)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Impact Factor
Scopus SNIP
Altmetric
11.492
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Language english
Publication Year 2021
HGF-reported in Year 2021
ISSN (print) / ISBN 2001-1326
e-ISSN 2001-1326
Journal Clinical and translational medicine
Quellenangaben Volume: 11, Issue: 9, Pages: , Article Number: e547 Supplement: ,
Publisher Springer
Publishing Place The Atrium, Southern Gate, Chichester Po19 8sq, W Sussex, England
Reviewing status Peer reviewed
Institute(s) Research Unit Analytical Pathology (AAP)
CF Pathology & Tissue Analytics (CF-PTA)
CF Metabolomics & Proteomics (CF-MPC)
POF-Topic(s) 30205 - Bioengineering and Digital Health
30505 - New Technologies for Biomedical Discoveries
30203 - Molecular Targets and Therapies
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-500390-001
A-630600-001
G-505700-001
Grants Deutsche Forschungsgemeinschaft
DOI 10.1002/ctm2.547
WOS ID WOS:000700900300009
PubMed ID 34586736
Erfassungsdatum 2021-10-18
[➜Report correction]